X2S Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinopharm Group Co Ltd

Watchlist Manager

Watchlist

Price: 1.943 EUR 0.31% Market Closed

Market Cap: €6.1B

S	Sinopharm Group Co Ltd F:X2S	CN
S	Semtech Corp F:SM2	US
I	Intertek Group PLC F:IT1	UK
C	China Literature Ltd F:C2X	CN
E	Eutelsat Communications SA XMUN:E3B	FR
	Fope SpA MIL:FPE	IT
	Paladin Energy Ltd ASX:PDN	AU
A	Aptose Biosciences Inc F:LTIA	CA
E	Ellaktor SA ATHEX:ELLAKTOR	GR
	clearvise AG F:ABO	DE

Profitability Summary

Sinopharm Group Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Declining Gross Margin

8% > 7%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

2% > 3%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.